Biperiden
An anticholinergic medication used to treat symptoms of Parkinson's disease and drug-induced movement disorders such as akathisia and dystonia. It reduces tremor, rigidity, and muscle spasms by blocking muscarinic receptors in the brain. Common side effects include dry mouth, constipation, and urinary retention.
Molecular Weight
311.5000 g/mol
LogP
4.30
TPSA
23.50 Ų
Lipinski RO5
Pass
Therapeutic Areas
Mechanism of Action
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
2D Structure
Cite this structure
Embed this structure
SMILES
OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2
InChI
InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2
Molecular Formula
C21H29NO
HBD / HBA
1 / 2
Rotatable Bonds
5
Heavy Atoms
23
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Frequently Asked Questions
An anticholinergic medication used to treat symptoms of Parkinson's disease and drug-induced movement disorders such as akathisia and dystonia. It reduces tremor, rigidity, and muscle spasms by blocking muscarinic receptors in the brain. Common side effects include dry mouth, constipation, and urinary retention.
Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.
Yes, Biperiden is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1101. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 2381. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="biperiden"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/biperiden/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/biperiden/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/biperiden/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="biperiden"></drugfyi-drug>